ID
26213
Beschrijving
Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00673829
Link
https://clinicaltrials.gov/show/NCT00673829
Trefwoorden
Versies (1)
- 11-10-17 11-10-17 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
11 oktober 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00673829
Eligibility Breast Cancer NCT00673829
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Systemic steroids Patient need for
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2825233
- UMLS CUI [1,2]
- C0686904
Beschrijving
Medical condition Serious
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3843040
- UMLS CUI [1,2]
- C0205404
Beschrijving
Malignant Neoplasms
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
Similar models
Eligibility Breast Cancer NCT00673829
- StudyEvent: Eligibility
C0012634 (UMLS CUI [2,1])
C0205179 (UMLS CUI [2,2])
C1517927 (UMLS CUI [2,3])
C1519810 (UMLS CUI [2,4])
C0017262 (UMLS CUI [1,2])
C0007082 (UMLS CUI [1,3])
C0487602 (UMLS CUI [1,4])
C2229606 (UMLS CUI [2,1])
C3163633 (UMLS CUI [2,2])
C0034571 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
C1273390 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C0205170 (UMLS CUI [1,2])
C0686904 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])